Peer Review reports
From: Fibrolamellar hepatocellular carcinoma treated with atezolizumab and bevacizumab: two case reports
| Original Submission | ||
|---|---|---|
| 9 Nov 2020 | Submitted | Original manuscript |
| 19 Nov 2020 | Reviewed | Reviewer Report - Swastik Agrawal |
| 26 Nov 2020 | Reviewed | Reviewer Report - Krishna Irrinki |
| 12 Jan 2021 | Author responded | Author comments - ALI ALZAHRANI |
| Resubmission - Version 2 | ||
| 12 Jan 2021 | Submitted | Manuscript version 2 |
| 16 Jan 2021 | Reviewed | Reviewer Report - Krishna Irrinki |
| 24 Jan 2021 | Reviewed | Reviewer Report - Swastik Agrawal |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| Publishing | ||
| 26 Jan 2021 | Editorially accepted | |
| 16 Mar 2021 | Article published | 10.1186/s13256-021-02695-8 |
You can find further information about peer review here.